May 2nd 2024
Study explores how the Inflation Reduction Act’s Drug Price Negotiation Program and its maximum fair prices impact incentives for investments in post-approval activity.
The end or just the beginning? Exploring federal preemption of state marketing and distribution laws
Multiplying state laws on marketing and distribution disclosures might be pre-empted by new federal legislation